Erasca ERAS
NASDAQ ERAS
$14.56 -0.10 (-0.68%)
As of: Oct 1, 2026 · 12:00 PM EDT

Erasca (ERAS) Other Non-Current Liabilities (2021 - 2026)

Updated

Erasca (ERAS) reported Other Non-Current Liabilities of $341,000 for Q2 2026, up 29.7% from $263,000 a year earlier and up 0.3% from the prior quarter.

Analysis

Erasca (ERAS) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2025, Erasca posted Other Non-Current Liabilities of $399,000, up 10.2% from FY2024.

  • Other Non-Current Liabilities has a four-year compound annual growth rate of 26.1% (FY2021 to FY2025).
  • By year, Other Non-Current Liabilities came in at $362,000 in FY2024 (-36.0%), $566,000 in FY2023 (-1.2%), $573,000 in FY2022 (+262.7%) and $158,000 in FY2021.
  • Five-year quarterly Other Non-Current Liabilities spans a low of $82,000 in Q2 2024 and a high of $761,000 in Q3 2023.
  • Year over year, Other Non-Current Liabilities has now increased in each of the last five quarters, with growth averaging 20.7% over the last eight quarters.
  • The high point for year-over-year Other Non-Current Liabilities in five years was Q4 2022 (growth of 262.7%); the low point was Q2 2024 (a decline of 88.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $340,000 (Q1 2026), $399,000 (Q4 2025) and $395,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Erasca 4.58 Bn 4.58 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 341,000.00
Mar 31, 2026 340,000.00
Dec 31, 2025 399,000.00
Sep 30, 2025 395,000.00
Jun 30, 2025 263,000.00
Mar 31, 2025 251,000.00
Dec 31, 2024 362,000.00
Sep 30, 2024 340,000.00
Jun 30, 2024 82,000.00
Mar 31, 2024 559,000.00
Dec 31, 2023 566,000.00
Sep 30, 2023 761,000.00
Jun 30, 2023 697,000.00
Mar 31, 2023 630,000.00
Dec 31, 2022 573,000.00
Dec 31, 2021 158,000.00
API Access

Erasca Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ERAS&period=max&api_key=YOUR_API_KEY